Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsBiotechnology EquipmentPOC Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1790280

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1790280

Point Of Care Molecular Diagnostics Market Size, Share & Trends Analysis Report By Application (Infectious Diseases, Oncology, Prenatal Testing, Endocrinology), By Technology, By Test Location, By End-use, By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Point-of-Care Molecular Diagnostics Market Summary

The global point of care molecular diagnostics market size was estimated at USD 8.22 billion in 2024 and is projected to reach USD 14.47 billion by 2033, growing at a CAGR of 6.52% from 2025 to 2033. This market focuses on rapid and accurate molecular testing conducted near the patient, enabling timely clinical decision-making. These platforms are used across various applications, particularly in infectious disease detection, respiratory illnesses, and sexually transmitted infections.

Market growth is driven by the rising demand for decentralized testing, especially in resource-limited settings and emergency care environments. The increasing burden of infectious diseases and the need for rapid turnaround time have expanded the adoption of point-of-care molecular technologies. Technological advances in microfluidics, isothermal amplification, and portable PCR systems are enhancing the accuracy and usability of these diagnostics. In addition, post-pandemic healthcare priorities emphasize rapid response testing, further supporting market expansion.

Moreover, POC molecular diagnostics in primary care settings range from simple glucose testing to complex coagulation testing. In several clinics, professionals are switching to POC testing from conventional lab testing, which helps shorten the time taken to decide whether further tests are required by avoiding delays during specimen preparation and transport. Other advantages of POC molecular diagnostics are rapid availability of results, lower costs, and better outcomes. The point of care molecular diagnostics industry has grown rapidly in the past few years, especially in the U.S. and European countries, owing to increased awareness regarding various issues such as medical & organizational concerns and economic advantages of POCT.

Aging is influenced by the interaction of several environmental and genetic factors and is characterized as the single most substantial risk factor for cancer development. Based on the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) Database, 38% of women and 43% of men are estimated to develop cancer during their lifetime. Nearly two-thirds of all new cancer cases are diagnosed in people aged 65 and above, which highlights that aging can make people more vulnerable to cancer. This is where molecular diagnostics play an important role, as it has a tremendous impact on the management of cancer, infectious diseases, and cardiovascular diseases. It is, therefore, vital for public health surveillance and detection. Thus, the growing geriatric population is expected to drive market growth.

Moreover, market players are continuously involved in the development of novel POC testing products to capitalize on market opportunities. For instance, in February 2023, Huwel Lifesciences designed a portable RT-PCR machine to test types of viruses. The company claimed that the test takes around 30 minutes and can be used to detect respiratory and other infections using blood and gastrointestinal samples. Moreover, in April 2023, Curative, Inc. announced the spin-off of Sensible Diagnostics, focusing on the commercialization of a novel POC PCR testing platform to provide results within 10 minutes with high accuracy.

Global Point Of Care Molecular Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global point of care molecular diagnostics market report based on application, technology, test location, end-use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • PCR-based
  • Genetic Sequencing-based
  • Hybridization-based
  • Microarray-based
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Infectious Diseases
    • HIV POC
    • Clostridium difficile POC
    • HBV POC
    • Pneumonia or Streptococcus associated infections
    • Respiratory syncytial virus (RSV) POC
    • HPV POC
    • Influenza/Flu POC
    • HCV POC
    • MRSA POC
    • TB and drug-resistant TB POC
    • HSV POC
    • Other Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Other Applications
  • Test Location Outlook (Revenue, USD Million, 2021 - 2033)
  • OTC
  • POC
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Decentralized Labs
  • Hospitals
  • Home-care
  • Assisted Living Healthcare Facilities
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: 978-1-68038-886-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Growing Demand for Rapid and Decentralized Testing
    • 3.4.2. Rising Prevalence of Infectious Diseases
    • 3.4.3. Technological Advancements in Molecular Platforms
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Molecular POC Devices and Consumables
    • 3.5.2. Regulatory and Quality Assurance Challenges
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Point-of-Care Molecular Diagnostics Market: Technology Movement Analysis
  • 4.2. PCR-based
    • 4.2.1. PCR-based Market, 2021 - 2033 (USD Million)
  • 4.3. Genetic Sequencing-based
    • 4.3.1. Genetic Sequencing-based Market, 2021 - 2033 (USD Million)
  • 4.4. Hybridization-based
    • 4.4.1. Hybridization-based Market, 2021 - 2033 (USD Million)
  • 4.5. Microarray-based
    • 4.5.1. Microarray-based Market, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Point-of-Care Molecular Diagnostics Market: Application Movement Analysis
  • 5.2. Infectious Diseases
    • 5.2.1. Infectious Diseases Market, 2021 - 2033 (USD Million)
    • 5.2.2. HIV POC
      • 5.2.2.1. HIV POC Market, 2021 - 2033 (USD Million)
    • 5.2.3. Clostridium difficile POC
      • 5.2.3.1. Clostridium difficile POC Market, 2021 - 2033 (USD Million)
    • 5.2.4. HBV POC
      • 5.2.4.1. HBV POC Market, 2021 - 2033 (USD Million)
    • 5.2.5. Pneumonia or Streptococcus associated infections
      • 5.2.5.1. Pneumonia or Streptococcus associated infections Market, 2021 - 2033 (USD Million)
    • 5.2.6. Respiratory Syncytial Virus (RSV) POC
      • 5.2.6.1. Respiratory Syncytial Virus (RSV) POC Market, 2021 - 2033 (USD Million)
    • 5.2.7. HPV POC
      • 5.2.7.1. HPV POC Market, 2021 - 2033 (USD Million)
    • 5.2.8. Influenza/Flu POC
      • 5.2.8.1. Influenza/Flu POC Market, 2021 - 2033 (USD Million)
    • 5.2.9. HCV POC
      • 5.2.9.1. HCV POC Market, 2021 - 2033 (USD Million)
    • 5.2.10. MRSA POC
      • 5.2.10.1. MRSA POC Market, 2021 - 2033 (USD Million)
    • 5.2.11. TB and drug-resistant TB POC
      • 5.2.11.1. TB and drug-resistant TB POC Market, 2021 - 2033 (USD Million)
    • 5.2.12. HSV POC
      • 5.2.12.1. HSV POC Market, 2021 - 2033 (USD Million)
    • 5.2.13. Other Infectious Diseases
      • 5.2.13.1. Other Infectious Diseases Market, 2021 - 2033 (USD Million)
  • 5.3. Oncology
    • 5.3.1. Oncology Market, 2021 - 2033 (USD Million)
  • 5.4. Hematology
    • 5.4.1. Hematology Market, 2021 - 2033 (USD Million)
  • 5.5. Prenatal Testing
    • 5.5.1. Prenatal Testing Market, 2021 - 2033 (USD Million)
  • 5.6. Endocrinology
    • 5.6.1. Endocrinology Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Test Location Business Analysis

  • 6.1. Point-of-Care Molecular Diagnostics Market: Test Location Movement Analysis
  • 6.2. OTC
    • 6.2.1. OTC Market, 2021 - 2033 (USD Million)
  • 6.3. POC
    • 6.3.1. POC Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Point-of-Care Molecular Diagnostics Market: End Use Movement Analysis
  • 7.2. Decentralized Labs
    • 7.2.1. Decentralized Labs Market, 2021 - 2033 (USD Million)
  • 7.3. Hospitals
    • 7.3.1. Hospitals Market, 2021 - 2033 (USD Million)
  • 7.4. Homecare
    • 7.4.1. Home-care Market, 2021 - 2033 (USD Million)
  • 7.5. Assisted Living Healthcare Facilities
    • 7.5.1. Assisted Living Healthcare Facilities Market, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Point-of-Care Molecular Diagnostics Market Share By Region, 2024 & 2033
  • 8.2. North America
    • 8.2.1. North America Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Target Disease Prevalence
      • 8.2.2.3. Competitive Scenario
      • 8.2.2.4. Regulatory Framework
      • 8.2.2.5. Reimbursement Scenario
      • 8.2.2.6. U.S. Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD MILLION)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. Canada Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Mexico Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. Reimbursement Scenario
      • 8.3.2.6. Germany Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. UK Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. France Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. Italy Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Spain Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Denmark Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Sweden Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Norway Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Reimbursement Scenario
      • 8.4.2.6. Japan Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. China Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. India Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. South Korea Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. Australia Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Thailand Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Reimbursement Scenario
      • 8.5.2.6. Brazil Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Argentina Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Reimbursement Scenario
      • 8.6.2.6. South Africa Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. Saudi Arabia Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. UAE Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. Kuwait Point-of-Care Molecular Diagnostics market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant's overview
  • 9.2. Financial performance
  • 9.3. Participant categorization
    • 9.3.1. Market Leaders
    • 9.3.2. Point-of-Care Molecular Diagnostics Market Share Analysis, 2023
    • 9.3.3. Company Profiles
      • 9.3.3.1. Abbott
        • 9.3.3.1.1. Company Overview
        • 9.3.3.1.2. Financial Performance
        • 9.3.3.1.3. Product Benchmarking
        • 9.3.3.1.4. Strategic Initiatives
      • 9.3.3.2. Bayer AG
        • 9.3.3.2.1. Company Overview
        • 9.3.3.2.2. Financial Performance
        • 9.3.3.2.3. Product Benchmarking
        • 9.3.3.2.4. Strategic Initiatives
      • 9.3.3.3. F. Hoffmann-La Roche AG
        • 9.3.3.3.1. Company Overview
        • 9.3.3.3.2. Financial Performance
        • 9.3.3.3.3. Product Benchmarking
        • 9.3.3.3.4. Strategic Initiatives
      • 9.3.3.4. Nova Biomedical
        • 9.3.3.4.1. Company Overview
        • 9.3.3.4.2. Financial Performance
        • 9.3.3.4.3. Product Benchmarking
        • 9.3.3.4.4. Strategic Initiatives
      • 9.3.3.5. QIAGEN
        • 9.3.3.5.1. Company Overview
        • 9.3.3.5.2. Financial Performance
        • 9.3.3.5.3. Product Benchmarking
        • 9.3.3.5.4. Strategic Initiatives
      • 9.3.3.6. Nipro Diagnostics
        • 9.3.3.6.1. Company Overview
        • 9.3.3.6.2. Financial Performance
        • 9.3.3.6.3. Product Benchmarking
        • 9.3.3.6.4. Strategic Initiatives
      • 9.3.3.7. Danaher
        • 9.3.3.7.1. Company Overview
        • 9.3.3.7.2. Financial Performance
        • 9.3.3.7.3. Product Benchmarking
        • 9.3.3.7.4. Strategic Initiatives
      • 9.3.3.8. Bio-Rad Laboratories, Inc.
        • 9.3.3.8.1. Company Overview
        • 9.3.3.8.2. Financial Performance
        • 9.3.3.8.3. Product Benchmarking
        • 9.3.3.8.4. Strategic Initiatives
      • 9.3.3.9. bioMerieux
        • 9.3.3.9.1. Company Overview
        • 9.3.3.9.2. Financial Performance
        • 9.3.3.9.3. Product Benchmarking
        • 9.3.3.9.4. Strategic Initiatives
      • 9.3.3.10. Agilent Technologies, Inc.
        • 9.3.3.10.1. Company Overview
        • 9.3.3.10.2. Financial Performance
        • 9.3.3.10.3. Product Benchmarking
        • 9.3.3.10.4. Strategic Initiatives
      • 9.3.3.11. Abaxis
        • 9.3.3.11.1. Company Overview
        • 9.3.3.11.2. Financial Performance
        • 9.3.3.11.3. Product Benchmarking
        • 9.3.3.11.4. Strategic Initiatives
      • 9.3.3.12. OraSure Technologies
        • 9.3.3.12.1. Company Overview
        • 9.3.3.12.2. Financial Performance
        • 9.3.3.12.3. Product Benchmarking
        • 9.3.3.12.4. Strategic Initiatives
    • 9.3.4. Strategy Mapping
      • 9.3.4.1. Expansion
      • 9.3.4.2. Acquisition
      • 9.3.4.3. Collaborations
      • 9.3.4.4. Disease Type/Drug Class Launch
      • 9.3.4.5. Partnerships
      • 9.3.4.6. Others
Show more
Product Code: 978-1-68038-886-2

List of Tables

  • Table 1. Point-of-care Molecular Diagnostics Market - Industry Snapshot & Key Buying Criteria, 2021 - 2033
  • Table 2. Global Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 3. Global Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 4. Global Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 5. Global Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 6. Global Point-of-care Molecular Diagnostics Market, by region, 2021 - 2033 (USD Million)
  • Table 7. Point-of-care Molecular Diagnostics- Key market driver analysis
  • Table 8. Point-of-care Molecular Diagnostics- Key market restraint analysis
  • Table 9. North America Point-of-care Molecular Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 10. North America Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 11. North America Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 12. North America Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 13. North America Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 14. U.S. Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 15. U.S. Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 16. U.S. Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 17. U.S. Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 18. Canada Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 19. Canada Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 20. Canada Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 21. Canada Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 22. Mexico Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 23. Mexico Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 24. Mexico Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 25. Mexico Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 26. Europe Point-of-care Molecular Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 27. Europe Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 28. Europe Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 29. Europe Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 30. Europe Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 31. Germany Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 32. Germany Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 33. Germany Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 34. Germany Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 35. UK Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 36. UK Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 37. UK Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 38. UK Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 39. France Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 40. France Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 41. France Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 42. France Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 43. Italy Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 44. Italy Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 45. Italy Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 46. Italy Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 47. Spain Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 48. Spain Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 49. Spain Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 50. Spain Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 51. Denmark Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 52. Denmark Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 53. Denmark Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 54. Denmark Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 55. Sweden Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 56. Sweden Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 57. Sweden Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 58. Sweden Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 59. Norway Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 60. Norway Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 61. Norway Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 62. Norway Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 63. Asia Pacific Point-of-care Molecular Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 64. Asia Pacific Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 65. Asia Pacific Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 66. Asia Pacific Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 67. Asia Pacific Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 68. Japan Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 69. Japan Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 70. Japan Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 71. Japan Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 72. China Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 73. China Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 74. China Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 75. China Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 76. India Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 77. India Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 78. India Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 79. India Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 80. Australia Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 81. Australia Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 82. Australia Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 83. Australia Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 84. South Korea Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 85. South Korea Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 86. South Korea Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 87. South Korea Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 88. Thailand Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 89. Thailand Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 90. Thailand Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 91. Thailand Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 92. Latin America Point-of-care Molecular Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 93. Latin America Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 94. Latin America Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 95. Latin America Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 96. Latin America Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 97. Brazil Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 98. Brazil Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 99. Brazil Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 100. Brazil Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 101. Argentina Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 102. Argentina Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 103. Argentina Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 104. Argentina Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 105. MEA Point-of-care Molecular Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 106. MEA Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 107. MEA Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 108. MEA Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 109. MEA Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 110. South Africa Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 111. South Africa Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 112. South Africa Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 113. South Africa Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 114. Saudi Arabia Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 115. Saudi Arabia Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 116. Saudi Arabia Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 117. Saudi Arabia Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 118. UAE Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 119. UAE Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 120. UAE Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 121. UAE Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)
  • Table 122. Kuwait Point-of-care Molecular Diagnostics Market, by application, 2021 - 2033 (USD Million)
  • Table 123. Kuwait Point-of-care Molecular Diagnostics Market, by technology, 2021 - 2033 (USD Million)
  • Table 124. Kuwait Point-of-care Molecular Diagnostics Market, by test location, 2021 - 2033 (USD Million)
  • Table 125. Kuwait Point-of-care Molecular Diagnostics Market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Point-Of-Care Molecular Diagnostics Market Segmentation
  • Fig. 2 Global Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 3 Point-Of-Care Molecular Diagnostics Market Dynamics
  • Fig. 4 Key Opportunities Prioritized, 2018
  • Fig. 5 Point-Of-Care Molecular Diagnostics Market - Porter's Analysis
  • Fig. 6 Point-Of-Care Molecular Diagnostics Market - PESTEL Analysis
  • Fig. 7 Point-Of-Care Molecular Diagnostics Revenue Share, By Application, 2024 & 2033
  • Fig. 8 POC Mdx Infectious Diseases Market, 2021 - 2033 (USD Million)
  • Fig. 9 POC Mdx Oncology Market, 2021 - 2033 (USD Million)
  • Fig. 10 POC Mdx Hematology Market, 2021 - 2033 (USD Million)
  • Fig. 11 POC Mdx Prenatal Testing Market, 2021 - 2033 (USD Million)
  • Fig. 12 POC Mdx Endocrinology Market, 2021 - 2033 (USD Million)
  • Fig. 13 POC Mdx Other Applications Market, 2021 - 2033 (USD Million)
  • Fig. 14 Point-Of-Care Molecular Diagnostics Revenue Share, By Technology, 2024 & 2033
  • Fig. 15 POC Mdx PCR-Based Market, 2021 - 2033 (USD Million)
  • Fig. 16 POC Mdx Genetic Sequencing-Based Market, 2021 - 2033 (USD Million)
  • Fig. 17 POC Mdx Hybridization-Based Market, 2021 - 2033 (USD Million)
  • Fig. 18 POC Mdx Microarray-Based Market, 2021 - 2033 (USD Million)
  • Fig. 19 Point-Of-Care Molecular Diagnostics Revenue Share, By Test Location, 2024 & 2033
  • Fig. 20 POC Mdx Over-The-Counter Market, 2021 - 2033 (USD Million)
  • Fig. 21 POC Mdx Point-Of-Care Market, 2021 - 2033 (USD Million)
  • Fig. 22 Point-Of-Care Molecular Diagnostics Revenue Share, By End Use, 2024 & 2033
  • Fig. 23 POC Mdx Decentralized Labs Market, 2021 - 2033 (USD Million)
  • Fig. 24 POC Mdx Hospitals Market, 2021 - 2033 (USD Million)
  • Fig. 25 POC Mdx Home-Care Market, 2021 - 2033 (USD Million)
  • Fig. 26 POC Mdx Assisted Living Healthcare Facilities Market, 2021 - 2033 (USD Million)
  • Fig. 27 POC Mdx Other Uses Market, 2021 - 2033 (USD Million)
  • Fig. 28 Point-Of-Care Molecular Diagnostics Revenue Share, By Test Location, 2024 & 2033
  • Fig. 29 POC Mdx OTC Market, 2021 - 2033 (USD Million)
  • Fig. 30 POC Mdx POC Market, 2021 - 2033 (USD Million)
  • Fig. 31 Point-Of-Care Molecular Diagnostics Revenue Share, By Region, 2024 & 2033
  • Fig. 32 North America Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 33 US Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 34 Canada Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 35 Mexico Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 36 Europe Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 37 Germany Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 38 UK Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 39 France Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 40 Italy Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 41 Spain Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 42 Denmark Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 43 Sweden Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 44 Norway Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 45 Asia Pacific Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 46 Japan Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 47 China Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 48 India Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 49 Australia Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 50 South Korea Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 51 Thailand Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 52 Latin America Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 53 Brazil Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 54 Argentina Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 55 MEA Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 56 South Africa Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 57 Saudi Arabia Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 58 UAE Point-Of-Care Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 59 Kuwait Point-Of-Care Molecular Diagnostics Market, 2021 - 2033(USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!